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Abstract
Marek’s Disease Virus (MDV) is an alphaherpesvirus that infects chickens, transforms
CD4+ T cells and causes deadly lymphomas. In addition, MDV induces immunosuppression
early during infection by inducing cell death of the infected lymphocytes, and potentially due
to activation of regulatory T (Treg)-cells. Furthermore, immunosuppression also occurs dur-
ing the transformation phase of the disease; however, it is still unknown how the disease
can suppress immune response prior or after lymphoma formation. Here, we demonstrated
that chicken TGF-beta+ Treg cells are found in different lymphoid tissues, with the highest
levels found in the gut-associated lymphoid tissue (cecal tonsil: CT), fostering an immune-
privileged microenvironment exerted by TGF-beta. Surprisingly, significantly higher fre-
quencies of TGF-beta+ Treg cells are found in the spleens of MDV-susceptible chicken lines
compared to the resistant line, suggesting an association between TGF-beta+ Treg cells
and host susceptibility to lymphoma formation. Experimental infection with a virulent MDV
elevated the levels of TGF-beta+ Treg cells in the lungs as early as 4 days post infection,
and during the transformation phase of the disease in the spleens. In contrast to TGF-beta+
Treg cells, the levels of CD4+CD25+ T cells remained unchanged during the infection and
transformation phase of the disease. Furthermore, our results demonstrate that the induc-
tion of TGF-beta+ Treg cells is associated with pathogenesis of the disease, as the vaccine
strain of MDV did not induce TGF-beta+ Treg cells. Similar to human haematopoietic malig-
nant cells, MDV-induced lymphoma cells expressed high levels of TGF-beta but very low
levels of TGF-beta receptor I and II genes. The results confirm that COX-2/ PGE2 pathway
is involved in immunosuppression induced by MDV-lymphoma cells. Taken together, our
results revealed a novel TGF-beta+ Treg subset in chickens that is activated during MDV
infection and tumour formation.
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Author summary
Treg cells are crucial for the maintenance of tolerance and control of immune responses,
especially during viral infection and tumour formation. Marek’s Disease Virus (MDV)
infection causes immunosuppression and induces transformation of CD4+ T cells in
chicken. Here we demonstrate that a population of chicken CD4+ T cells express inhibi-
tory molecules including TGF-beta and have immune-regulatory properties. TGF-beta+
Treg cells are detected in different chicken lymphoid tissues, the highest being detected in
cecal tonsils. Chicken lines susceptible to MDV-induced lymphoma formation have
higher frequencies of TGF-beta+ Treg cells compared to the MDV resistant chicken line.
Infection of chicken with a virulent MDV increased the numbers of TGF-beta+ Treg cells,
which was not changed after infection with the MDV vaccine strain. MDV-transformed
CD4+ T cells produce high levels of TGF-beta, while they express very low levels of TGF-
beta receptors compared to non-transformed CD4+ T cells. In addition, MDV-induced
lymphoma cells express soluble suppressive factors that can inhibit T cell function; how-
ever these soluble factors cannot suppress proliferation of the lymphoma cells. For the
first time, we identified chicken TGF-beta+ Treg cells and demonstrate that these cells are
involved in pathogenesis and immunosuppression of MDV infection.
Introduction
Regulatory T cells (Tregs) are critical for maintenance of immune-homeostasis and immuno-
logical tolerance by enforcing negative regulation on T helper (Th) cells. Transcription factor
Foxp3 (Foxp3) is a lineage specific factor for human and murine CD4+CD25+ Treg cells and
is crucial for Treg development and function. TGF-beta can bind to the surface of human
Foxp3+ Treg cells via GARP (LRRC32) a membrane anchoring molecule, and these cells can
be classified as activated Treg cells with a highly potent immune-regulatory properties [1–3].
In chickens, CD4+CD25+ T cells have been classified as Treg cells which are present in
most tissues including thymus [4] thus, they are thought to be equivalent to mammalian natu-
ral regulatory T cells (nTreg cells). Interestingly, expression of Foxp3 is restricted to jawed ver-
tebrate and no Foxp3-like genes has been identified in the chicken genome [5]. Therefore,
CD25 is currently the only marker for identification of Treg but CD25 is also a marker for acti-
vated T cells [2]. Apart from immune regulatory activity, Tregs cells are implicated in progres-
sion of the tumour and pathogenesis of viral as well as bacterial diseases in humans and mice.
Depletion of tumour-induced Treg cells can reduce tumour progression via the activation of T
cell responses [6–9]. It has been postulated that Treg cells are involved in the development of
malignant lymphomas, however, their role is more complex in lymphoma than that in other
cancers such as carcinomas [10]. Transformed CD4+ T cells (lymphoma) may express inhibi-
tory markers, and suppress anti-tumour immunity. Therefore, Treg cells isolated from malig-
nant lymphoma patients can be categorized as primary Treg cells or malignant Treg cells [10].
Marek’s Disease (MD) is caused by a highly contagious alphaherpesvirus, Marek’s Disease
Virus (MDV), leading to development of malignant CD4+ T cell lymphoma in domestic chick-
ens. The pathogenesis of the MD can be classified into three distinct phases: i) the early cyto-
lytic phase with the infection of B and T cells which is associated with transient
immunosuppression, ii) the latency phase which is defined by absence of viral protein expres-
sion and viral replication and iii) the transformation phase that leads to a deadly lymphoma.
In MD-susceptible chicken lines, a second cytolytic phase may occur, resulting in atrophy of
lymphoid tissues and a severe immunosuppression [11]. During the early phase of infection,
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both T and B cells are the predominant target cells for MDV infection in the thymus, spleens
and the bursa of Fabricius. MDV replicates in the infected B and T cells, resulting in a deple-
tion of lymphocytes and transient immunosuppression in the host [12]. The activation of T
cells via the antigen presenting B cells is important for the establishment of primary infection,
as the resting T cells are resistant to the MDV infection [13].
Here we identified and characterized TGF-beta+ Treg cells in chickens and demonstrated
that MD-susceptible chicken lines have higher levels of TGF-beta+ Treg cells. Infection with
virulent virus, but not vaccine strains, increased the number of TGF-beta+ Treg cells. Interest-
ingly, MDV-induced lymphoma cells adopt a Treg phenotype and release soluble molecules
that can inhibit T cell function. Taken together, our results suggest that activated Treg cells
may be involved in MDV-induced immunosuppression in chickens.
Results
A population of CD4+ T cells express membrane bound TGF-beta
CD25 molecule is not only a marker for identification of human and murine Treg cells but
also for activated T cells. We confirmed this observation in chickens by analysing the surface
expression levels of CD25 on CD4+ T cells isolated from spleens (3 weeks old Rhode Island
Red (RIR) chickens) upon activation with Con-A or PHA. As expected, addition of Con-A or
PHA to splenocytes increased the expression of CD25 molecules on the activated CD4+ T cells
3 days after in vitro activation (Fig 1A). Another marker for identification of a subpopulation
of human Treg cells is membrane bound TGF-beta. To examine whether chicken Treg cells
also express membrane bound TGF-beta, mononuclear cells from different tissues (blood,
spleen, lungs, cecal tonsil, and thymus) were isolated from RIR chickens (3 weeks old) and
stained with anti-CD4 and anti-TGF-beta mAbs. Flow cytometry analysis of these cells re-
vealed that a subpopulation of chicken CD4+ T cells express membrane bound TGF-beta (Fig
1B). The next step was to determine whether membrane bound TGF-beta are preferentially
expressed on CD4+CD25+ T cells or CD4+CD25- T cells. CD4+ T cells were subdivided into
three subpopulations; CD25-, CD25low and CD25high CD4+ T cells, and the expression of TGF-
beta was analysed in these three subpopulations. The data revealed that TGF-beta is expressed
on both CD4+CD25- and CD4+CD25+ T cells, however a higher percentages of CD4+CD25high
T cells expressed TGF-beta compared to CD4+CD25- T cells (Fig 1C). Only 15–20% of TGF-
beta+CD4+ T cells expressed CD25 molecules (Fig 1D), suggesting that TGF-beta+CD4+ T
cells and CD4+CD25+ T cells are two distinct cell types with some overlap. Flow cytometry
analysis of surface expression of TGF-beta on CD4+ cells show that TGF-beta+CD4+ T cells are
present in various lymphoid tissues including spleen, cecal tonsils, lungs, and blood of chick-
ens (Fig 1B, C and 1E). Intriguingly, unlike CD4+CD25+ T cells, TGF-beta+CD4+ T cells were
not found in thymus of chickens (Fig 1E), indicating that TGF-beta+CD4+ T cells are induced
in the periphery. In addition, confocal microscopy confirmed that a population of primary
CD4+ T cells express TGF-beta as both an intracellular and membrane bound form (Fig 1F).
One of the immune-regulatory functions of human and murine Tregs is their ability to
inhibit T cell proliferation in vitro. Hence, we utilized a typical inhibitory T cell proliferation
assay to examine the inhibitory properties of chicken TGF-beta+CD4+ T cells. The cells were
isolated from spleens of 3-weeks old RIR chickens and the CFSE-labelled responder cells were
co-cultured with TGF-beta+CD4+ T cells or TGF-beta-CD4+ T cells and were stimulated with
Concanavalin (Con)-A, and the proliferation of T cells were analysed 3 days after co-culture
using flow cytometry. The result demonstrated that TGF-beta+CD4+ T cells reduced T cell
proliferation in vitro (Fig 1G), suggesting that these cells exhibit immune-regulatory activity.
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A defining characteristic of human CD4+ Treg cells is their defect in phosphorylation of
AKT at S473 [14]. To determine the AKT phosphorylation levels in chicken TGF-beta+ Treg
cells, mononuclear cells from 3-weeks old RIR chickens were isolated and were stimulated
with PMA for 15 minutes. AKT phosphorylation at S473 were analysed within TGF-beta+
Treg cells and TGF-beta-CD4+ T cells using Phosflow. Fig 1H demonstrates that chicken TGF-
beta+ Treg cells (R1 gate) have lower AKT activation at S473 compared to TGF-beta- CD4+ T
cells (R2 gate), confirming that chicken TGF-beta+ Tregs have also a defect in phosphorylation
of AKT.
As described above, we demonstrated that TGF-beta+ Treg cells are present in various tis-
sues of chickens. However, the highest frequencies of these cells were found in cecal tonsils
(CT) as detected using flow cytometry (Fig 1E). A representative of Forward and Sideward
scatter of cells isolated from different tissues including spleens, blood, lungs, thymus and CT
are shown (S1A Fig). Exclusion of dead cells (7AAD positive cells) (Fig 1E) and the light
microscopy of the cells isolated from CT demonstrated that these cells are alive and intact (S1B
Fig). Various subsets of Treg cells that promote immunological non-responsiveness have been
suggested to be involved in sustaining immune privilege in the gastrointestinal tract under
normal homeostatic conditions. Here we demonstrated that the frequencies of both TGF-
beta+CD4+ cells and CD4+CD25+ T cells in the CT of RIR chickens (3 weeks old) were signifi-
cantly higher than that observed in the spleens (p = 0.002, n = 8) (Fig 2A, 2B and 2C). We also
examined the differential expression levels of inhibitory molecules including CTLA-4, IL-10,
PDL1 and PD1 in CD4+ T cells from CT and spleens of RIR chickens using semi-quantitative
RT-PCR. Chicken CD4+ T cells isolated from CT expressed significantly higher levels of inhib-
itory genes including CTLA-4, PD1 and IL-10 compared to the cells isolated from the spleens
(Fig 2D). Another characteristic of Treg cells is their ability to inhibit the production of proin-
flammatory Th1 cytokines such as IFN-gamma. To analyse the differential IFN-gamma
expression in CT and spleens, mononuclear cells isolated from spleens and CT of RIR chickens
were stimulated with PMA and Ionomycin for 4hrs and the expression of IFN-gamma gene
was determined using semi-quantitative RT-PCR. The results confirmed that the cells isolated
from CT are unable to up-regulate the expression of IFN-gamma gene (Fig 2E). Similarly, we
observed a significantly lower frequencies of IFN-gamma producing T cells in mononuclear
cells isolated from CT, stimulated with PMA and Ionomycin for 18 hrs, compared to that from
the spleens using chicken IFN-gamma ELISPOT assay (Fig 2F). Generally, Treg cells exhibit
Fig 1. Identification and characterization of chicken TGF-beta+ Treg cells. A) Mononuclear cells isolated from the spleens of 3 weeks old RIR birds
were independently cultured in the presence of media only, rIL-2, PHA or Con-A at 40˚C. After 72 hrs, the cells were stained with anti-CD4, and anti-
CD25; 7AAD staining was used for dead cell exclusion. Data (mean ± SD) represents the percentages of CD4+CD25+ T cells in different cell culture
conditions. The results are representative of three independent experiments with three biological replicates. (B) Representative FACS profiles and
percentages TGF-beta+CD4+ T cells within CD4+ T cell population are shown. Mononuclear cells, isolated from spleens of 3 weeks-old naïve RIR
chickens, were stained with anti-CD4-PE, anti-TGF-beta-APC mAbs and/ or isotype controls. The 7AAD was added for exclusion of dead cells. C)
Representative of FACS profile and percentages TGF-beta+CD4+ T cells within three subpopulations: CD25high (R1); CD25low (R2); CD25-ve(R3) CD4+ T
cells are shown. D) The percentages of CD25+ cells within TGF-beta+CD4+ T cells are shown. E) TGF-beta expressions on gated CD4+ T cells isolated
from lungs, thymus, cecal tonsil, and blood of 3-weeks old RIR chickens were analysed using flow cytometry. The number in each quadrant represents
percentages of the cells. The results are representative of data obtained from one out of six chickens. F) The intracellular staining of TGF-beta (Red) and
cell surface CD4 (green) are shown using confocal microscopy. Mononuclear cells from spleen were stained with primary mouse anti-chicken CD4
(IgG2b), and mouse anti-TGF-beta (IgG1) monoclonal antibodies followed by staining with anti-mouse IgG1-Alexa Flur 488 or IgG2b-Alexa Flur 568
secondary antibodies, respectively. DAPI was used to visualize the nucleus. G) In vitro inhibitory function of TGF-beta+CD4+ T cells using a CFSE based
proliferative assay 72 hrs after co-culture. CFSE-labelled responder cells were co-cultured with or without TGF-beta+CD4+ T cells in the presence or
absence of 2.5 μg/mL Con-A. Filled grey profiles represent non-stimulated controls without co-culturing with TGF-beta+CD4+ T cells. Empty profiles
represent stimulation with 2.5 μg/mL Con-A in co-culture with TGF-beta+ CD4+ T cells (green lines), or without co-culturing with TGF-β+CD4+ T cells (red
lines). H) Ex vivo splenocytes isolated from RIR chickens were stimulated with PMA and stained for CD4 and TGF-beta. The levels of Phospho-AKT were
analysed using Phosflow by gating on CD4+TGF-beta+ (R1) or CD4+TGF-beta- (R2) T cells. Filled grey profiles represent isotype control, thin lines
represent non-activated cells, and thicker lines represent the expression of Phospho-AKT in PMA-activated cells. The percentages of cells expressing
Phospho-AKT for activated cells are shown for the two sub-populations. The results represent of at least three independent experiments.
https://doi.org/10.1371/journal.ppat.1006745.g001
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Fig 2. High concentrations of Treg cells in cecal tonsils is associated with immune-privileged microenvironment.
Mononuclear cells were isolated from spleens or cecal tonsils of six 3-weeks old RIR birds and were stained with anti-
CD4-PE, CD25-FITC, and TGF-beta-APC or isotype controls. 7AAD was used for dead cell exclusion, and the cells were
analysed using FACS. Percentages of (A) TGF-beta+CD4+ T cells (B), CD4+CD25+ T cells (C) TGF-beta+CD4+CD25+ T
cells in the spleens and cecal tonsils are shown. (D) Relative quantification of the CTLA-4, IL-10, PDL1 and PD1 molecules
in cecal tonsils over spleen mononuclear cells. Fold change was calculated in non-stimulated cecal tonsils considering
normalized Ct value for respective molecule from spleen as baseline. (E) Relative quantification of fold change in IFN-γ
gene in cecal tonsils and spleens after 4 h of stimulation with PMA/Ionomycin were determined using RT-PCR. (F) The
frequencies of IFN-γ producing cells in cecal tonsils and spleens were determined using chicken-IFN-gamma ELISPOT
assay 18 hrs after PMA/Ionomycin stimulation. (G) CFSE histograms from one representative of T cell proliferation in cecal
tonsils and (H) in splenocytes are shown following stimulation with 2.5 μg/ml Con-A. Empty profiles with solid line represent
non-stimulated control cells and the grey shaded area represents Con A-stimulated cells. (I) Graphical representation of
proliferation index in Con-A stimulated and non-stimulated mononuclear cells from spleens and cecal tonsils of seven birds
are shown. (J) Relative quantification of the IL-2 cytokine gene in PMA/Ionomycin stimulated cecal tonsils and spleen
mononuclear cells. The fold change in mRNA for IL-2 cytokine in stimulated cells was calculated over non-stimulated cells
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reduced proliferative response in the absence of rIL-2 in vitro. The unresponsiveness of mono-
nuclear cells isolated from CT was demonstrated in a CFSE-based proliferation assay. In con-
trast to mononuclear cells from spleens, the cells isolated from CT did not proliferate in
response to Con-A stimulation (Fig 2G and 2H). Fig 2I shows proliferation index of mononu-
clear cells from CT cells compared to splenocytes. The results show that CT cells are unrespon-
sive and do not proliferate after the stimulation. One of the mechanisms involved in Treg-
induced suppression is their ability to inhibit IL-2 mRNA expression [15]. To examine
whether T cells from CT can respond to the stimulation and up-regulate IL-2 genes, CD4+ T
cells from CT and spleens of RIR chickens were stimulated with PMA and Ionomycin for 4 hrs
and IL-2 mRNA expression was analysed using RT-PCR. IL-2 expression was not upregulated
in CT, while IL-2 gene expression was significantly increased in the cells isolated from spleens
(Fig 2J). To examine the role of TGF-beta in providing an inhibitory microenvironment in
CT, the mononuclear cells from CT were treated with either anti-TGF-beta or control MAbs
and the cells were stimulated with Con A, and the proliferation was analysed using a CFSE-
based proliferation assay. The treatment of mononuclear cells isolated from CT with anti-
TGF-beta blocking antibody, but not an isotype control MAb, increased their ability to prolif-
erate in vitro (Fig 2K). Con-A was used in all T cell proliferation assays performed in this
study. Unlike Con-A, PMA (ranging from 12.5–100 ng/ml) did not stimulate chicken T cell
proliferation (S2 Fig). Taken together, the above results suggest that high concentration of
TGF-beta+ Treg cells in CT is associated with immune-privileged microenvironment in the
largest gut associated lymphoid tissues in chickens, and TGF-beta is involved in the induction
of unresponsiveness to the stimulation in CT.
To understand how TGF-beta+ Treg cell are generated in vivo, we developed a protocol for
generation of chicken Treg cells in vitro. CD4+ T cells isolated from RIR chickens were cul-
tured for 1–3 days in the presence of plate-bound anti-chicken CD3 antibody. TGF-beta
expression was up-regulated on CD4+ T cells 3 days after culture with anti-CD3 antibody (Fig
3A). Addition of rIL-2 increases the expression of TGF-beta on CD4+ T cells (Fig 3B). These in
vitro generated TGF-beta+ Treg cells inhibited T cell proliferation upon Con-A-stimulation
(Fig 3C), indicating that these cells have immune-regulatory activity. Activation of CD4+ T
cells or splenocytes with PMA, PHA or Con-A did not induce TGF-beta expression on chicken
CD4+ T cells (ranging from 4.5 to 7% of CD4+ T cells; p = 0.6).
Higher frequencies of TGF-beta+ Treg cells is associated with
susceptibility to MDV-induced CD4+ T cell lymphoma
The genetic background plays an important role in the susceptibility of chicken lines to the for-
mation of MDV-induced lymphoma. While, the resistant lines display fewer tumours than sus-
ceptible lines, the resistant lines will develop tumours, just at a much-reduced rate (e.g. line P
and line 7 birds being susceptible and line N birds being resistant to lymphoma formation).
MDV infection induces immunosuppression, however the exact mechanisms involved in
MDV-induced immunosuppression is still unknown [11]. Mononuclear cells from the spleens
of aged matched naïve chickens from four different chicken lines (line P, line 7, line N and
RIR) were isolated and counted prior to staining for flow cytometry analysis. The results
showed that there was no significant difference in the total numbers of splenocytes (ranging
from 52 to 68 x 106 cells) and total CD4+ T cells among these chicken lines (p = 0.6). The cells
after normalizing against housekeeping gene. (K) anti-TGF-beta blocking antibody partially restored the proliferation of
mononuclear cells isolated from CT using CFSE-based proliferation assay. Data are shown as means with standard
deviations (error bars) of at least of three independent experiments. ns, not significant.
https://doi.org/10.1371/journal.ppat.1006745.g002
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were stained with anti-CD4, anti-CD25 and anti-TGF-beta antibodies and the percentages of
TGF-beta+CD4+ T cells, TGF-beta+CD4+CD25+ and CD4+CD25+ T cells were analysed using
flow cytometry. The MD-susceptible line P and 7 had significantly higher percentages of TGF-
beta+CD4+ T cells (Fig 4B) and TGF-beta+CD4+CD25+ T cells (Fig 4C) than the MD-resistant
line N, demonstrating that there is an association between high frequencies of TGF-beta+ Treg
cells in the spleens and susceptibility to MDV-induced lymphoma formation (p = 0.0008).
Intriguingly, there were no significant differences in the frequencies of CD4+CD25+ T cells
(Fig 4D) among these chicken lines.
Infection with an oncogenic MDV increases the frequencies of TGF-
beta+ Treg cells in the susceptible line
Virulent MDV strains cause immunosuppression and efficiently transform CD4+ T cells
resulting in deadly lymphoma [11]. To assess the impact of MDV infection on TGF-beta+ Treg
cells in vivo, one day old line P chickens were infected via intra-tracheal route with the virulent
MDV strain RB1B. Spleen samples were taken from infected and mock-infected birds during
(1) early phase of infection at 4 days post infection (dpi), (2) latent phase at 11 dpi, and (3) the
transformation phase of MD at 21 and 28 dpi (Fig 5A). Mononuclear cells were stained with
anti-CD4, anti-CD25 and anti-TGF-beta mAbs, and 7AAD was used for the exclusion of dead
cells. The percentages and absolute numbers of TGF-beta+CD4+ T cells were determined by
flow cytometry. A significant increase (p<0.05, n = 5) in the percentages of TGF-beta+CD4+ T
cells was observed in the spleens of MDV infected birds at 21 dpi (Fig 5D and 5E), while there
was no difference in the percentages of total CD4+CD25+ T cells (Fig 5B) or CD4+CD25high T
cells (Fig 5C) between the infected and mock infected birds at any time points post infection.
The absolute numbers of TGF-beta+ Treg cells were calculated and the data confirm that
MDV-infection leads to an increase in both percentages and absolute numbers of TGF-beta+
Fig 3. Induction of TGF-beta+CD4+ T cells in vitro. (A) Representative of overlapping histogram demonstrating the expression levels of TGF-beta on
gated CD4+ T cells isolated from 3-weeks old RIR chickens. Ex vivo CD4+ T cells (green line), CD4+ T cells stimulated with anti-CD3 mAb for 24 hours (red
line), and 72 hrs (black line) are shown. Dotted line represents cells stained with isotype control antibody, (B) Compares the expression levels of TGF-beta
on CD4+ T cells ex vivo (green line), or cells stimulated with anti-CD3 and rIL-2 (black line), and cells stimulated with only anti-CD3 mAb (red line) at 72 hours
after stimulation. (C) The numbers of live cells (7AAD negative) are shown after co-cultured of the responder cells with non-Treg cells (TGF-beta- Treg cells)
(black bar) or Treg cells (TGF-beta+CD4+ T cells) (open bar) 72hrs after stimulation with Con-A. Grey bar represents the numbers of live cells in co-culture of
the responder cells and TGF-beta-CD4+ T cells without stimulation. A representative of three independent experiments is shown.
https://doi.org/10.1371/journal.ppat.1006745.g003
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Treg cells at 21 dpi (Fig 5F). However, no difference was found in the percentages or absolute
numbers of TGF-beta+ Treg cells between infected and non-infected birds in the spleens at 4,
11, or 28 dpi (Fig 5). Analysis of mean fluorescent intensities (MFI) of TGF-beta expression on
CD4+ T cells demonstrated that TGF-beta expression levels were significantly increased on
CD4+CD25+ T cells (p = 0.008, n = 5), but not on CD4+CD25- T cells, at 21 dpi (Fig 5G and
5H).
As MDV initially infects lung epithelial cells, we hypothesized that TGF-beta+ Treg cells
may be induced in the lungs prior to an increase in their frequencies in spleens. FACS analyses
Fig 4. High concentrations of TGF-beta+CD4+ T cells in susceptible birds to virus-induced lymphoma. A) Gating strategy for detection of TGF-
beta+ Treg cells are shown. Mononuclear cells were isolated from spleens of 3 weeks-old naïve chicken lines, and were surface stained with anti-
CD4-PE, anti-CD25-FITC and anti-TGF-beta-APC mAbs or isotype controls. The 7AAD staining was used for dead cell exclusion. The percentages and
mean fluorescent intensity (MFI) of CD4+ cells expressing TGF-beta are shown in FACS density plots. The percentages of (B) TGF-beta+CD4+ T cells,
(C) TGF-beta+CD4+CD25+ T cells and (D) CD4+CD25+ T cells in different chicken lines are shown. The values are representative from five different
birds for each group. The mean ± SD value are shown. * indicates a statistically significant difference (P < 0.05); ns, not significant.
https://doi.org/10.1371/journal.ppat.1006745.g004
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revealed that a higher percentage of TGF-beta+ Treg cells are detected in the lung tissues iso-
lated from MDV-infected birds compared to mock-infected chickens at 4 dpi (p = 0.004) (Fig
5I), while no increase in the percentages of these cells were observed in the spleens at this time.
There was also no difference in the percentages of CD4+CD25+ (ranging from 10.5 to 11.5% of
CD4+ T cells; p = 0.4) or CD4+CD25high (ranging from 4.5 to 5.3% of CD4+ T cells; p = 0.4) T
cells in infected and non-infected lung tissues. The results indicate that the induction of TGF-
beta+ Treg cells occur at an earlier stage of infection in the lungs.
An increase in the levels of TGF-beta+ Treg cells is associated with
pathogenesis of the disease
In this animal experiment, we set to address three questions regarding to the effects of MDV
infection on chicken TGF-beta+ Treg cells; Does the expansion occur (i) in other chicken lines
(ii) upon infection via other routes (iii) with oncogenic and vaccine strains of the virus. To
address these questions, RIR birds, an outbred chicken line which is moderately susceptible to
MDV lymphoma formation, were selected for this experiment. The birds were infected via the
intra-abdominal route with the oncogenic virus (RB-1B), the vaccine strains (CVI988-Rispens)
or non-infected CEF cells (mock infected group). This route of infection is routinely used to
study MDV pathogenesis. Similar to line P birds, there were no changes in the frequencies of
total CD4+CD25+ T cells (Fig 6A), or CD4+CD25high T cells (Fig 6B) on 21 dpi. In contrast, the
percentages (Fig 6C) of TGF-beta+CD4+ T cells were increased (p = 0.003) in the MDV-
infected birds. The attenuated MDV vaccine CVI988-Rispens, (98% sequence identity with
Fig 5. Infection with virulent virus induces TGF-beta+ Treg cells in vivo. (A) A schematic diagram of animal trials is shown. Day old line P chicks were
mock-infected or infected with the virulent virus via intra-tracheal route. Spleens were taken from 5 birds at different time points post infection. Percentages
of (B) CD4+CD25+ T cells (C) CD4+CD25high T cells (D) TGF-beta+CD4+ T cells (E) TGF-beta+CD4+CD25+ T cells are shown. (F) Absolute numbers of
TGF-beta+ Treg cells are shown at 21 dpi. (G) Representative flow cytometry plots isolated from splenocytes of non-infected and MDV-infected chickens
depicting the expression levels of TGF-beta within CD4+CD25- or CD4+CD25+ T cell at 21 dpi. Dashed lines (Isotype control), solid line (CD4+CD25- T
cells), and shaded grey (CD4+CD25+ T cells). (H) Bar graph (mean ± SD) shows of MFIs of TGF-beta expression within CD4+CD25+ T cells and
CD4+CD25- T cells in non-infected and MDV infected chickens (n = 5). (I) The percentages of TGF-beta+CD4+ T cells within mononuclear cells isolated
from the lungs at 4 dpi are depicted. * indicates a statistically significant difference (P < 0.05); ns, not significant.
https://doi.org/10.1371/journal.ppat.1006745.g005
Fig 6. Induction of TGF-beta+ Treg cells is association with pathogenesis of the disease. Day-old RIR chicks were administered via intra-
abdominal route with 1,000 PFU cell associated RB1B (n = 14), 1,000 PFU cell associated CVI988-Rispens (n = 8), or CEF only (n = 8). The spleens
were taken at 21 dpi and the percentages of TGF-beta+ Treg cells were determined using FACS. Data are mean ± SD (A) CD4+CD25+ T cells (B)
CD4+CD25high T cells, and (C) TGF-β+CD4+ Treg cells. * indicates a statistically significant difference (P < 0.05); ns, not significant.
https://doi.org/10.1371/journal.ppat.1006745.g006
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RB1B) which can infect and replicate in chickens, but cannot induce lymphoma formation,
did not induce TGF-beta+ Treg (Fig 6C). We also assessed the absolute numbers of TGF-beta
Treg cells in the vaccinated group and compared it with that in the control birds. In average,
the numbers of splenocytes isolated from vaccinated group were not significantly increased
(60–87 x 106 cells per spleen) compared to the CEF control group (61–83 x 106 cells per spleen)
at 21 dpi. Similarly the absolute numbers of TGF-beta Treg cells were not altered after vaccina-
tion (7.3± 1.2 x 105 cells in vaccinated compared to 7.62 ± 0.85 105 cells in the control group
per spleen).These results reveal that the induction of TGF-beta+ Treg cells is associated with
pathogenesis of the disease and it can also occur in outbred chickens.
Next we examined if the oncogenic RB1B strain also induces TGF-beta Treg cells in a MDV
resistant chicken. One day old line N chickens were infected with 1,000 pfu RB1B via intra-
abdominal route and the frequencies of TGF-beta Treg cells were compared with the control
group (non-infected) 3-weeks post infection using flow cytometry as described above. As
expected, no obvious gross pathology was observed in the infected MDV resistant chickens at
3-weeks post infection. The results demonstrated that the infection with the oncogenic virus
does not increase the frequencies of TGF-beta Treg cells in the MDV resistant chicken line
(TGF-beta Treg cells as % of CD4 T cells were 1.95± 0.54 in the infected chickens compared to
%1.86± 0.47 in the control group).
TGF-beta+ MDV-transformed lymphoma cells exert immuno-regulatory
activity
TGF-beta pathway has been linked to tumour progression because it plays an essential role in
modulation of cell proliferation and migration [16]. At different stages of tumour develop-
ment, TGF-beta can either inhibit or promote tumour growth. There is evidence suggesting
that overexpression of TGF-beta is associated with poor prognosis in human cancers [17, 18].
Expression of TGF-beta was analysed in spleen tissues obtained from MDV or mock infected
line P chickens 3 months post infection, when gross pathological lesions were evident. Tissues
were stained with anti-CD4 and anti-TGF-beta antibodies and analysed by confocal micros-
copy. In mock infected animals, only a small number of CD4+ T cells in the splenic T cell zone
co-expressed TGF-beta (Fig 7Ai and 7Aii). In contrast, the majority of CD4+ T cells in the
infected spleens expressed TGF-beta as demonstrated by co-localization of CD4 and TGF-beta
molecules (Fig 7Bi and 7Bii). Similar to the primary lymphoma cells, MDV-transformed CD4+
T cell clone (clone 265L; generated from line P) expressed both membrane bound (Fig 7C)
and intracellular TGF-beta (Fig 7D), as demonstrated using flow cytometry and confocal
microscopy, respectively. Approximately 20% of MDV-induced lymphoma cells expressed
membrane bound TGF-beta (Fig 7C), while the majority of the lymphoma cells expressed
intracellular TGF-beta (Fig 7D). The expression of TGF-beta was not exclusive to 265L clones,
as 15–22% of MSB1 clone also expressed mTGF-beta. Interestingly, MDV-induced lymphoma
cells (265L) did not express CD25 molecules (Fig 7C). As TGF-beta can act as both paracrine
and autocrine factor to inhibit T cell proliferation, we determined the gene expression levels of
TGF-beta receptor I and II in 265 L cells (MDV-induced lymphoma cells from line P) using
quantitative RT-PCR. MDV-induce lymphoma cells expressed significantly lower levels of
TGF-beta receptors compared to the primary naïve CD4+ T cells isolated from line P birds
(Fig 7E), suggesting that these cells may be resistant to inhibitory effects of TGF-beta on prolif-
eration. Human lymphoma cells may produce many inhibitory factors such as PGE2, VEGF,
IL-10 and TGF-beta that can suppress T cell function, and several of these factors may be
involved in the induction of Treg cells. In transwell experiments (splenocytes isolated from
RIR birds were cultured in the lower chamber and 265L cells in the upper chamber), 265L cells
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inhibited Con-A induced T cell proliferation in vitro in a contact independent manner (Fig
7F). As expected, addition of cell culture supernatant from 265 L lymphoma cells (as low as 5%
supernatant/ cell culture media ratio) also inhibited T cell proliferation 3 days after stimulation
(Fig 7G), while the addition of supernatant to the cell culture had no effect on proliferation of
lymphoma cells even at high ratios (60% supernatant/ cell culture media ratio). Fig 7I depicts
the proliferation rate of lymphoma cells, in the presence (coloured histograms) or absence
(grey histograms) of the supernatant, 24–96 hrs after culture using a CFSE-based proliferation
assay. The results suggest that MDV-lymphoma cells express inhibitory factors that can sup-
press T cell proliferation in a contact independent manner, while it has no effect on the prolif-
eration of the lymphoma cells. One of the inhibitory molecules produced by MDV-lymphoma
cells is TGF-beta, which has been shown to inhibit T cell function in vitro [19]. To determine
whether TGF-beta produced by the tumour cells can also exert inhibitory effects on T cells,
splenocytes isolated from RIR birds were stimulated with Con-A in the presence of the tumour
supernatant (5% of total volume) and anti-TGF-beta blocking antibody or a control antibody.
The results demonstrate that anti-TGF-beta antibody could not restore T cell function, indicat-
ing that other factors secreted by those tumour cells are likely to be more important. To exam-
ine the role of COX-2/PGE2 pathway in the inhibitory effects of MDV-induced lymphoma
cells, splenocytes isolated from RIR birds were stimulated with Con-A in the presence of the
tumour supernatant (5% of total volume) with or without cyclooxygenase-2 (COX-2) inhibitor
(SC-236) and anti-TGF-beta blocking antibody. The results demonstrate that COX-2 inhibitor
can partially restore T cell proliferation and treatment with both COX-2 inhibitor and anti-
TGF-beta blocking MAb further increased Con A-induced T cell proliferation (Fig 7I).Taken
together, our data demonstrate that PGE2 and TGF-beta are involved in the inhibition of T
cell function in a contact independent manner.
Discussion
Early studies identified a population of human and murine CD4+ T cells that co-express high
levels of CD25, IL-2 receptor α-chain, and demonstrated that these cells are essential for main-
tenance of peripheral self-tolerance [20]. Because activation of T cells can lead to upregulation
of CD25 molecules, subsequent studies proposed Foxp3, a member of the fork-head/winged-
helix family of transcriptional factor, as a unique marker for identification of human and
murine naturally occurring Treg cells. However, activated human T cells may also transiently
expressed Foxp3 [21, 22]. The presence of Foxp subfamily members including Foxp3 is limited
to jawed vertebrates and Foxp3-like genes are not found in chicken [5]. Here we show that a
subpopulation of chicken CD4+ T cells express membrane bound TGF-beta, an inhibitory
Fig 7. MDV-induced CD4+ lymphoma cells express TGF-beta. Confocal microscopy of spleen sections from non-infected (Ai and Aii; two different
magnifications) and MDV-infected birds (Bi and Bii; two different magnifications) are shown. CD4+ T cells (green) and TGF-beta+ cells (red) and nuclei
(DAPI; Blue) are depicted. (C) A representative FACS histogram showing membrane bound TGF-beta on MDV-induced CD4+ lymphoma (265L); dotted
lines (isotype control MAb) and shaded grey (anti-TGF-beta mAb). (D) Confocal microscopy of MDV-induced CD4+ T cell lymphoma cell line (265L)
expressing intracellular TGF-beta (red) and nuclei (DAPI; Blue). (E) The variation in the absolute copy number of mRNA transcript for TGF-beta
receptor I (red) and TGF-beta receptor II (blue) receptor in 265L and primary CD4+ T cells. The ct values for TGF-beta receptor I and II were normalized
against the GAPDH house keeping gene and plotted in the standard curve. Results are mean ± S.E.M. of five independent replicates. The tissues are
representative of six different infected and non-infected birds. The results from tumour cell lines are representative of 10 different experiments. (F) 265L
lymphoma cells inhibited T cell proliferation in a transwell experiment. Splenocytes (in the lower chamber) were stimulated with Con-A, while 265L
lymphoma cells were cultured in the upper chamber. T cell proliferation was analysed 3 days after the stimulation using a CFSE-based proliferation
assay. (G) Cell culture supernatant from 265L lymphoma cells (5% of total cell culture media) inhibited T cell proliferations. Splenocytes were cultured in
100% media or 95% media and 5% supernatant and T cell proliferation was analysed after Con-A stimulation using CFSE-based proliferation assay. (H)
265L lymphoma cells were resistant to the effects of soluble factors. 265L lymphoma cells were cultured in 100% media or 60% supernatant plus 40%
media and the proliferation was analysed using a CFSE-based proliferation assay. (I)Treatment of the cells with SC-236 (PGE2 inhibitor) alone or in
combination with TGF-beta blocking antibody partially restored T cell proliferation.
https://doi.org/10.1371/journal.ppat.1006745.g007
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cytokine that possess immune-regulatory properties. The results demonstrate that TGF-
beta+CD4+ T cells are distinct from CD4+CD25+ T cells as the majority of TGF-beta+CD4+ T
cells do not express CD25 molecules.
Intracellular signalling within human and murine Treg cells differs from that of effector T
cells. In the latter, activation of AKT results in cytoskeletal rearrangements, cytokine produc-
tion, cell-cycle progression and engagement of T-cell effector functions. In contrast, Treg cells
that are functionally hypo-responsive have a defect in AKT pathway [14], and AKT activation
can impair de novo induction of Treg cells by TGF-beta [23, 24]. Our data show that chicken
TGF-beta+ Treg cells have a defect in AKT phosphorylation, confirming that these cells are
hypo-responsive. In this study, we also demonstrated that chicken TGF-beta+ Treg cells are
present in the spleen, blood and lung of naïve birds, but, unexpectedly, these cells were not
found in the thymus. This suggests that chicken TGF-beta+ Treg cells are induced in the
periphery and that thymic Treg cells do not express membrane bound TGF-beta. However,
our result does not exclude the possibility that other cells in the thymus, e.g. apoptotic thymo-
cytes, may express and release TGF-beta which is known to be required for T cell development
in the thymus [25, 26]. Induction of TGF-beta+ Treg cells in the periphery could be induced by
stimulants such as TLR ligands and metabolites produced by gut microbial fermentation [27–
29]. Similar to human Treg cells, chicken TGF-beta+ Treg could be induced via activation of
non-Treg cells with plate-bound anti-CD3 antibody in vitro. However, it is unclear how exactly
TGF-beta+ Treg cells can be induced in vivo. It is possible that metabolites such as short chain
fatty acids produced by gut microbial fermentation induce TGF-beta+ Treg cells [29]. This
notion is supported by our results demonstrating that high frequencies of TGF-beta+ Treg
cells are found in the largest avian gut associated lymphoid tissue, cecal tonsil (CT). Mononu-
clear cells from CT were hypo-responsive and expressed inhibitory molecules, suggesting that
gut associated lymphoid tissues have an immuno-privileged microenvironment in the chick-
ens, and these cells can modulate the inflammatory response. Further work is required to
determine the exact mechanism involved in the induction of large numbers of TGF-beta+ Treg
cell in gut associated lymphoid tissues in chickens and study the role of gut TGF-beta+ Treg
cells in health and diseases of intestinal tract in chickens. The main function of TGF-beta+
CD4+ T cells in gut associated lymphoid tissues may be to act as T follicular helper cells and to
provide help for B cells to produce IgA, as well as suppress pro-inflammatory responses.
Viruses can trigger and expand both nTreg and induced regulatory T cells (iTregs) via
poorly understood mechanisms. It is believed that non-TCR mediated mechanisms, e.g. innate
ligands, may be involved in the induction of Treg cells. For example, it has been suggested that
hepatitis C and influenza viruses can increase circulating bioactive TGF-beta levels by activat-
ing latent TGF-beta [30, 31], an inhibitory cytokine which can induce Treg cells. On the other
hand, some viruses activate Treg cell expansion via ligation of TLR, induction of IL-2 and gen-
eration of inhibitory antigen presenting cells [32]. In this study, we demonstrated that RB1B
(very virulent MDV) can induce the expansion of Treg cells in the susceptible chicken lines.
Further studies are required to examine the effect of mild MDV or very virulent plus MDV on
Treg cell activation/expansion. Based on our data, it can be speculated that the formation of
tumour lesions in the host is associated with activation/expansion of Treg cells. High mortality
rates observed in the chickens infected with very virulent plus MDV may occur prior to the
formation of tumour. This may affect the expansion of Treg cells, however further experiments
are required to determine the effects of these viruses on Treg cell expansion/activation. Here,
we demonstrated that chicken lines that are genetically susceptible to Marek’s Disease (MD)
(line P and line 7) have intrinsically higher concentrations of TGF-beta+ Treg cells. At the time
of these experiments, we had no access to tissues from line 6 (another resistant line with simi-
lar MHC molecules as line 7) chickens. Therefore, we were unable to examine the frequencies
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of intrinsic TGF-beta Treg cells in these birds. However, these experiments are planned and
the transfer of TGF-beta Treg cells from line 7 (susceptible:B2 haplotype) to line 6 (resistant:
B2 haplotype) chickens will also provide further information on the role of TGF-beta Treg
cells in susceptibility to the disease. Our current results demonstrate an association between
susceptibility to virus-induced lymphoma and concentrations of Treg cells. This hypothesis is
in agreement with reports indicating that Treg cells can confer susceptibility to pathogens and
the removal of Treg cells protects the animals from the disease [33–36]. In our study, we did
not observe any differences in percentages of CD4+CD25+ or CD4+CD25high T cells in the
chicken lines, indicating that only TGF-beta+ Treg cells are associated with susceptibility to
MDV. But how can TGF-beta+ Treg cells contribute to increased susceptibility to MDV? It is
possible that TGF-beta+ Treg cells dampen down the inflammatory response induced by MDV
infection, leading to an increase in virus replication and expression of viral genes involved in
the transformation. This notion is supported by the results demonstrating that higher MDV
replication occurs in the susceptible chicken lines compared to the resistant lines [11]. Since
MDV is a cell-associated virus, it is believed that cell-mediated immunity plays an important
role in control of the disease. A suppressive effect of TGF-beta+ Treg cells on cell-mediated
immunity will result in enhanced susceptibility to the disease. The expression of TGF-beta by
MDV-transformed T cells indicates that these cells may exert their immuno-regulatory prop-
erties by production of this inhibitory cytokine. TGF-beta inhibits activation and proliferation
of naïve T cells, and induces apoptosis in activated T cells [37]. On the other hand, T cells
exposed to TGF-beta and IL-6, which is produced during inflammatory response, can develop
into Th17 cells, known to be involved in immunopathology [38]. It has been shown that IL-6
gene expression is upregulated in chicken lines that are susceptible to Marek’s Disease. [39].
Therefore, it is possible that induction of TGF-beta and IL-6 in the MDV-infected susceptible
birds can lead to the development of Th17 cells. In addition to the immunological effects of
TGF-beta, this cytokine can induce apoptosis of various cells including virus-infected cells or
transformed cells. How do MDV-induced lymphoma cells escape anti-proliferative effects of
autocrine and paracrine TGF-beta? Some cancer cells escape the tumour suppressor effects of
TGF-beta by down-regulation/mutation of the type 1 and 2 receptors, Smad2 and Smad4 [40].
It has been shown that a viral analog of cellular miR-155 in MDV, which is critical for oncoge-
nicity of MDV, down-regulate TGF-beta signalling [41]. In agreement with this report, our
results show that MDV-transformed TGF-beta+ lymphoma cells down-regulate TGF-beta
receptors, altering tumour suppressive activity of TGF-beta to tumour-promoting activity.
Lymphoma cells may release many inhibitory factors (TGF-beta, VEGF, PGE2, etc.) which can
cause immunosuppression. Here we demonstrated that COX-2 inhibitor can partially restore
the inhibitory effects of soluble factors released by the tumour cells confirming that MDV-
induced tumour cells modulate the function of immune cells via COX-2/PGE2 pathway. In
addition, we observed that anti-TGF-beta have synergistic effect with COX-2 inhibitors, while
has no or very negligible effect when it is used on its own. The results indicate that PGE2 and
TGF-beta released by lymphoma cells may be involved in the immunosuppression.
One of the prominent features of Marek’s Disease (MD) is a generalized immuno-suppres-
sion in chickens. The exact mechanism responsible for MDV-induced immuno-suppression
has not yet been defined [11]. As summarized in the proposed model shown in Fig 8, we dem-
onstrate that the induction and expansion of TGF-beta+ Treg cells are involved in MD-
induced immunosuppression. It should be noted that Treg cells and TGF-beta producing
tumour cells are probably induced by different mechanisms and are not necessarily the same
in either phenotype or behaviour. The effects of MDV infection on induction/expansion of
TGF-beta+ Treg cells suggest that these cells may be involved in pathogenesis of the disease,
and expansion of these cells can contribute to MDV-induced immunosuppression. This
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notion is supported by observation that the MDV vaccine strain (CVI988-Rispens) which
shares a 98% homology with virulent MDV strains does not trigger the induction of TGF-
beta+ Treg cells. Furthermore, we demonstrate that MDV-induced tumour cells produce
PGE2 and TGF-beta and perhaps other soluble factors that can inhibit T cell function, and
may contribute to MDV-induced immunosuppression after transformation phase of the dis-
ease. Taken together, our results indicate that Treg cells may be involved in MDV-induced
immunosuppression at early stage of infection and soluble factors produced by MDV-induced
lymphoma cells can cause immunosuppression.
Materials and methods
Ethics statement
All animal experiments were conducted based on the guidelines and care approved (project
license PPL 30/3169) by the UK government Home Office and the personnel involved in the
procedures had obtained personal license from the UK Home Office.
Animal experiments
SPF inbred chicken lines including line P (homozygous for the B19 haplotype), line N (homo-
zygous for the B21 haplotype), line 7 (homozygous for the B2 haplotype), and Rhode Island
Red (RIR; outbred chicken line) were raised and kept at isolation unit at The Pirbright Insti-
tute. Tissues (spleen, lungs, cecal tonsil, and thymus) were harvested after cervical dislocation
of the birds. In total, 40 one-day-old line P birds were inoculated with dusts via intra-tracheal
route using a Penn-Century device. Twenty a-day old line P birds per group were inoculated
with 5 mg of RB1B-containing chicken dust via intra-tracheal route or mock-infected controls.
The dust was collected from our previous experiment in which one-day-old RIR birds were
infected with CEF cells-RB1B (1,000 PFU) or mock-infected CEF cells via intra-abdominal
route. MDV-genome copies were confirmed in the dust using qPCR as previously described
[42]. Five MDV-infected birds and 5 mock-infected birds were taken at 4, 11, 21 and 28 dpi.
Replication of MDV (RB1B) was confirmed by analyzing genome copy numbers were above
1.00E+3 in spleens of birds using qPCR. MDV-infected birds showed splenomegaly in post-
Fig 8. Schematic of immunosuppression via induction of TGF-beta+ Treg during MDV infection. Upon infection with MDV via respiratory
route, TGF-beta+ Treg cells, but not CD4+CD25+TGF-betanegT cells, are expanded at 4 dpi in the lungs and at day 21 post infection in the spleens.
There is an association between the induction of TGF-beta+ Treg cells and immunosuppression/pathogenicity of the disease. TGF-beta+ MDV-
induced lymphoma cells express low levels of TGF-betaRI and II, while produce soluble inhibitory factors which can induce immunosuppression.
https://doi.org/10.1371/journal.ppat.1006745.g008
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mortem examination on 21 and 28 dpi. Day-old Rhode Island Red chickens were inoculated
with 1,000 PFU CEF cells-RB1B (oncogenic virus; n = 8), 1,000 PFU CEF cells-CVI988/Ris-
pens (vaccine strain; n = 8), or mock infected-CEF cells (controls only; n = 8) via the intra-
abdominal route, and splenocytes were harvested on 21 dpi for further analysis. Day-old line
N chicks (n = 3) were injected with 1,000 PFU RB1B via intra-abdominal route, and the fre-
quencies of TGF-beta+ Treg cells in the spleens were analysed 3-weeks post infection.
Virus preparation
A day-old Rhode Island Red (RIR) chickens were infected via the intra-abdominal route with
1,000 plaque forming units (PFU) of RB1B. Splenocytes were harvested at 14 dpi and were co-
cultured with primary CEF cells for 7 days. Once the cytopathic effects were observed, the cell-
associated MDV-infected CEF cells were passaged two times in fresh CEF to prepare virus
stocks. The virus stocks were titrated and stored in liquid nitrogen. Commercial CVI988/Ris-
pens vaccine virus (Nobilis Rismavac) was obtained from Intervet.
DNA preparation and real-time PCR
Dust samples were prepared as 5 mg aliquots and total DNA was isolated from dust samples
using a DNeasy kit (Qiagen, Manchester, UK). For absolute quantification of MDV genome
copies, we performed real-time quantitative duplex PCR (q-PCR) for the detections of the
MDV meq gene in DNS isolated from dust and splenoyctes. The chicken ovotransferrin (ovo)
was used as a reference gene as previously described [42]. Ten microgram bovine serum albu-
min was added to reactions using dust samples to block the inhibitory effect of melanin pig-
ment. MDV genomes (for 104 cells or 1 μg dust) were quantified using standard curves which
were calibrated against plasmid contracts of known target gene copy number.
Relative quantification of cytokine expression in cecal tonsils
Total RNA was isolated from CD4+ T cells isolated from splenocytes or cecal tonsils after stim-
ulation with PMA (50 ng/ml) and ionomycin (100 ng/ml) at 41˚C, 5% CO2 for 4 hrs. The
RNA was quantified and treated with DNA-free DNA removal kit (Thermo Fisher Scientific,
Paisley, UK) for removal of genomic DNA contamination and reverse transcribed into cDNA
with maxima H Minus First Strand cDNA Synthesis Kit according to the manufacturer’s
instruction (Thermo Fisher Scientific, Paisley, UK). Primer sequences for all target cytokines
and housekeeping genes are enlisted in S1 Table. The SYBR green based real-time PCR was
performed with a LightCycler 480 SYBR Green I Master kit (Roche Applied Science, USA).
The Quantitative PCR was performed in QuantStudio5 (Thermo Fisher Scientific, Paisley,
UK) with the following conditions: initial denaturation was performed at 95˚C for 1 min, fol-
lowed by 40 cycles of denaturation at 95˚C for 15s and annealing / extension at 60˚C for 30s,
with end point melt-curve analysis. The relative fold change of target genes in cecal tonsils was
calculated by 2−ΔΔCT method. The Ct value for each sample was normalized against GAPDH
housekeeping gene for respective sample. The amplified TGF-beta receptor I and II were
cloned in pGEMT-easy vector (Promega, USA) and used for generation of the standard curve
equation to calculate the absolute copy number of the genes.
Flow cytometry/ Phosflow
Mononuclear cells isolated from spleens, lungs; cecal tonsils, blood, and thymus were stained
with fluorochrome-conjugated monoclonal antibodies, and the expression of surface mole-
cules were analysed using flow cytometry. Prior to staining, the cells were incubated with
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chicken serum to block FC receptors, and then the cells were incubated with anti-CD4-PE
(Cambridge Bioscience, Cambridge, UK), anti-TGF-beta1,2,3 (R&D systems, Abingdon, UK),
anti-CD25 FITC mAbs (Bio-Rad, Watford, UK) at 4˚C for 15 min. The cells were washed
twice and 7-AAD staining was used to exclude dead cells. The minimal number of 100,000
cells was acquired for FACS analysis. Cells were acquired on a MACSQuant analyser and the
data were processed by FlowJo V10 software.
For Phosflow analysis of the cells, mononuclear cells were plated at 5.0 x105 cells per well
and stimulated (15 min; 41˚C, 5% CO2) with PMA (50 ng/ml) or cell culture media only. The
staining was conducted according to the manufacturer’s instruction as previously described
[43]. After fixation of the cells for 30 minutes using the fixation/ permeabilization kit (Thermo
Fisher Scientific, Paisley, UK), the cells were stained with anti-TGF-beta (R&D Systems, Abing-
don, UK) and anti-CD4 mAbs (Cambridge Bioscience, Cambridge, UK), and were permeabi-
lized using Perm buffer for 10 min at 4˚C, followed by staining with anti-AKT (S473) PE-
conjugated mAbs (BD Bioscience, Oxford, UK) at 4˚C for 30 minutes. The cells were washed
twice in Perm buffer and re-suspended in FACS buffer and acquired using flow cytometry.
Inhibitory T cell function assay
The inhibitory effects of TGF-beta+ Treg cells on T cell proliferation were analysed in an in
vitro inhibition assay. TGF-beta+ Treg and TGF-beta- CD4+ T cells were purified from spleno-
cytes using anti-PE and anti-APC micro-bead kits according to the manufacturer’s instruc-
tions (Miltenyi Biotec, Woking, UK). TGF-beta+ Treg cells or control cells were co-cultured
with the responder cells (CFSE-labelled splenocytes [depleted from TGF-beta+ Treg cells]; 3 X
104) at an effector/responder cell ratio of 1:1 in three replicates. The cells were stimulated with
2.5μg/ml Con-A to induce T cell proliferation. In each experiment, the cells from 7 birds were
pooled to isolate enough cells for the inhibition assays. T cell proliferation was analysed using
flow cytometry at 72 hrs after the co-culture, and proliferation index was calculated using
FlowJo v10.07.
For assessing the inhibitory effects of in vitro generated TGF-beta+ Treg cells, the responder
cells (3 x 104 cells/ well) were co-cultured with TGF-beta+ Treg cells or TGF-beta- CD4+ T cells
at an effector/responder ratio of 1:1 in three replicates as described above. The numbers of live
cells (7AAD negative) in the culture were counted using flow cytometry.
To study the role of PGE2 and TGF-beta in the inhibitory effects, the cells were treated with
10 μM SC-236 (COX-2 inhibitor) (Tocris, Abingdon, UK) and /or 1 μg/ml anti-TGF-beta
blocking antibody (clone 1D11) or a control MAb (mouse IgG1) (R&D Systems, Abingdon,
UK) prior to Con-A stimulation (2.5μg/ml).
Immunofluorescence microscopy
MDV-derived lymphoma cell lines were adhered to coverslips using Cell-Tak adhesive (BD
Bioscience, Oxford, UK). Tissues were immediately frozen in isopentane mixed with dry ice,
and the frozen samples were kept at -80˚C. Tissue sections were cut at 8μm and mounted on
gelatin-coated histological slides. Sections were fixed 4% paraformaldehyde at Room tempera-
ture for 1 hr and permeabilized in 0.1% Triton X100 in PBS for 10 minutes. After rehydration
and blocked (0.5% BSA in PBS), the tissue sections or cells were incubated with mouse anti-
chicken CD4 (IgG2b) (Cambridge Bioscience, Cambridge, UK), and mouse anti-TGF-beta
(IgG1) (R& D Systems, Abingdon, UK) overnight at 2–8˚C. An isotype matched control (R&D
Systems, Abingdon, UK) was used to identify non-specific staining. After three washes in PBS
at room temperature, the tissues/ cells were incubated with fluorochrome-labeled anti-mouse
IgG1 or IgG2b antibodies (Thermo Fisher Scientific, Paisley, UK), and DAPI solution was
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added for 10 minutes at room temperature. The sections were mounted onto glass slides using
Vectashield mounting medium, and coverslips were sealed with nail varnish before visualisa-
tion by confocal microscopy (Leica Microsystems).
Chicken IFN-gamma ELISPOT assay
Chicken ELISPOT assay was performed as described previously [43]. Briefly, nitrocellulose-
backed plates were coated with anti-chicken IFN-gamma capture antibody overnight at 4˚C.
The wells were washed and blocked using RPMI1640 containing 2% FCS (1hr at 41˚C). Mono-
nuclear cells were seeded (3 x106 cells/ml) and stimulated with Phorbol Myristate Acetate
(PMA; 50 ng/ml) and ionomycin (100 ng/ml) in six replicates and incubated at 41˚C for 18hrs.
The wells were washed with PBS and distilled water, and then incubated with anti-chicken
IFN-gamma biotin (1 μg / ml) (Thermo Fisher Scientific, Paisley, UK) for 1 h. After several
washes, the plate was incubated with 100 μl of streptavidin-HRP (1:1000) at 41˚C for 1 h. The
assay was developed with AEC substrate as per manufacturer’s instruction (BD Bioscience,
Oxford, UK). The reaction was terminated by washing plates under running water. The spots
were enumerated in the dried plate with ELISPOT reader (Advanced imaging devices, GmbH,
Germany). The counted spots were finally expressed as spot forming units (SFU) per million
mononuclear cells.
Cell culture and MDV-derived T cell lines
MDV-transformed CD4+ T-cell lines were cultured (41˚C, 5% CO2 incubator) in RPMI 1640
growth medium (Thermo Fisher Scientific, Paisley, UK); supplemented 100 μg/mL of penicil-
lin/streptomycin, 10% fetal calf serum, 10% tryptose phosphate broth, 1 mM sodium pyruvate;
(Sigma-Aldrich, Dorset, UK), and 50 μM 2-mercaptoethanol (Thermo Fisher Scientific, Pais-
ley, UK).
Statistical analyses
Statistical calculation included Wilcoxon and Mann Whitney non-parametric to determine
significance. Results were considered statistically significant at P< 0.05 ().Statistical analysis
of the data was performed using Graph Pad Prism 7. The data are presented as mean +-SD.
Supporting information
S1 Fig. (A) Representative of SSC-FSC and gating strategy of mononuclear cells isolated from
spleen, peripheral blood, cecal tonsil, and lung are shown. (B) Microscopy of mononuclear
cells isolated from cecal tonsil is demonstrated.
(TIF)
S2 Fig. (A) CFSE histograms from T cell proliferation of splenocytes in response to different
concentrations of Con-A or PMA are shown. (B) Graphical representation of proliferation
index in response to Con-A or PMA.
(TIF)
S1 Table. List of primers used for real-time PCR.
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